Clinical trials
Recruiting Scleroderma, Systemic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allogene Therapeutics | 1 |
| Boehringer Ingelheim | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Marie Hudson, MD | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| National Cancer Institute (NCI) | 1 |
| Primus Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 8 |
| Lupus Erythematosus, Systemic | 3 |
| Scleroderma, Diffuse | 3 |
| Autoimmune Diseases | 2 |
| Dermatomyositis | 2 |
| Lung Diseases, Interstitial | 2 |
| Arthritis, Psoriatic | 1 |
| Arthritis, Rheumatoid | 1 |
| Colitis, Ulcerative | 1 |
| Connective Tissue Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.